How large is the lung recruitability in early acute respiratory distress syndrome: a prospective case series of patients monitored by computed tomography

Carregando...
Imagem de Miniatura
Citações na Scopus
76
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
MATOS, Gustavo F. J. de
STANZANI, Fabiana
PASSOS, Rogerio H.
FONTANA, Mauricio F.
ALBALADEJO, Renata
CASERTA, Raquel E.
SANTOS, Durval C. B.
Citação
CRITICAL CARE, v.16, n.1, article ID R4, 14p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: The benefits of higher positive end expiratory pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS) have been modest, but few studies have fully tested the ""open-lung hypothesis"". This hypothesis states that most of the collapsed lung tissue observed in ARDS can be reversed at an acceptable clinical cost, potentially resulting in better lung protection, but requiring more intensive maneuvers. The short-/middle-term efficacy of a maximum recruitment strategy (MRS) was recently described in a small physiological study. The present study extends those results, describing a case-series of non-selected patients with early, severe ARDS submitted to MRS and followed until hospital discharge or death. Methods: MRS guided by thoracic computed tomography (CT) included two parts: a recruitment phase to calculate opening pressures (incremental steps under pressure-controlled ventilation up to maximum inspiratory pressures of 60 cmH(2)O, at constant driving-pressures of 15 cmH(2)O); and a PEEP titration phase (decremental PEEP steps from 25 to 10 cmH2O) used to estimate the minimum PEEP to keep lungs open. During all steps, we calculated the size of the non-aerated (-100 to +100 HU) compartment and the recruitability of the lungs (the percent mass of collapsed tissue re-aerated from baseline to maximum PEEP). Results: A total of 51 severe ARDS patients, with a mean age of 50.7 years (84% primary ARDS) was studied. The opening plateau-pressure was 59.6 (+/- 5.9 cmH(2)O), and the mean PEEP titrated after MRS was 24.6 (+/- 2.9 cmH(2)O). Mean PaO2/FiO(2) ratio increased from 125 (+/- 43) to 300 (+/- 103; P < 0.0001) after MRS and was sustained above 300 throughout seven days. Non-aerated parenchyma decreased significantly from 53.6% (interquartile range (IQR): 42.5 to 62.4) to 12.7% (IQR: 4.9 to 24.2) (P < 0.0001) after MRS. The potentially recruitable lung was estimated at 45% (IQR: 25 to 53). We did not observe major barotrauma or significant clinical complications associated with the maneuver. Conclusions: MRS could efficiently reverse hypoxemia and most of the collapsed lung tissue during the course of ARDS, compatible with a high lung recruitability in non-selected patients with early, severe ARDS. This strategy should be tested in a prospective randomized clinical trial.
Palavras-chave
Referências
  1. Amato MBP, 1997, ACUTE LUNG INJURY, V30, P258
  2. Amato MBP, 1996, AM J RESP CRIT CARE, V153, pA375
  3. Amato MBP, 1998, NEW ENGL J MED, V339, P196
  4. Barbas CSV, 2005, CURR OPIN CRIT CARE, V11, P18, DOI 10.1097/00075198-200502000-00004
  5. Blanch Lluis, 2002, Respir Care Clin N Am, V8, P281, DOI 10.1016/S1078-5337(02)00009-6
  6. Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005
  7. Bohm SH, 1998, YB INTENSIVE CARE EM, P430
  8. Borges JB, 2006, NEW ENGL J MED, V355, P319
  9. Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-97OC
  10. Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218
  11. Brower RG, 2004, NEW ENGL J MED, V351, P327
  12. Caironi P, 2010, AM J RESP CRIT CARE, V181, P578, DOI 10.1164/rccm.200905-0787OC
  13. Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC
  14. DAngelo E, 1997, EUR RESPIR J, V10, P2343, DOI 10.1183/09031936.97.10102343
  15. De Backer D, 2005, INTENS CARE MED, V31, P517, DOI 10.1007/s00134-005-2586-4
  16. DREYFUSS D, 1993, AM REV RESPIR DIS, V148, P1194
  17. Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294
  18. Dreyfuss D, 1994, PRINCIPLES PRACTICE, P793
  19. EGAN EA, 1982, J APPL PHYSIOL, V53, P121
  20. Estenssoro E, 2002, CRIT CARE MED, V30, P2450, DOI 10.1037/01.CCM.0000034692.46267.02
  21. Frank JA, 2003, ACUTE RESP DISTRESS, V179, P201
  22. Fujino Y, 2001, CRIT CARE MED, V29, P1579, DOI 10.1097/00003246-200108000-00014
  23. Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052
  24. Gattinoni L, 2005, CURR OPIN CRIT CARE, V11, P69, DOI 10.1097/00075198-200502000-00011
  25. Gattinoni L, 2003, CRIT CARE MED, V31, pS300, DOI 10.1097/01.CCM.0000057907.46502.7B
  26. Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701
  27. Girgis K, 2006, RESPIR CARE, V51, P1132
  28. LACHMANN B, 1992, INTENS CARE MED, V18, P319, DOI 10.1007/BF01694358
  29. Marini JJ, 2004, CRIT CARE MED, V32, P250, DOI 10.1097/01.CCM.0000104946.66723.A8
  30. Matos GFJ, 2010, CRITICAL CARE S1, V14, pP186
  31. Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637
  32. Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646
  33. Michard F, 1999, AM J RESP CRIT CARE, V159, P935
  34. Michard F, 2000, AM J RESP CRIT CARE, V162, P134
  35. MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327
  36. Papadakos PJ, 2007, CRIT CARE CLIN, V23, P241, DOI 10.1016/j.ccc.2006.12.001
  37. PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024
  38. Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54
  39. Richards GA, 2002, CRIT CARE MED, V30, P2169, DOI 10.1097/01.CCM.0000026739.95729.50
  40. Santos Claudia C dos, 2005, Crit Care, V9, P280
  41. Schreiter D, 2004, CRIT CARE MED, V32, P968, DOI 10.1097/01.CCM.0000120050.85798.38
  42. Suh GY, 2002, CRIT CARE MED, V30, P1848, DOI 10.1097/01.CCM.0000021177.83239.1A
  43. Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638
  44. Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC
  45. Brower RG, 2000, NEW ENGL J MED, V342, P1301
  46. Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259
  47. Vieillard-Baron A, 2002, CRIT CARE MED, V30, P726
  48. Vieillard-Baron A, 2001, CRIT CARE MED, V29, P1551, DOI 10.1097/00003246-200108000-00009
  49. Villagra A, 2002, AM J RESP CRIT CARE, V165, P165
  50. Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01
  51. Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4
  52. WEBB HH, 1974, AM REV RESPIR DIS, V110, P556